Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CytoRecovery is a private life science tools company developing and commercializing label-free cell sorting and recovery technologies for research use. The company’s core offering is the CytoR1 platform, a microfluidic system designed to sort, enrich, and recover rare, viable live cell subpopulations from tissue, blood, and other biological samples while maintaining high viability. Its product suite also includes disposable CytoChip kits and CytoBuffer, supporting start-to-finish experimental workflows for cell biology laboratories. The technology originated at Virginia Tech, with additional licensed intellectual property from the University of Virginia, and is positioned to support applications in oncology, regenerative medicine, stem cell research, and drug discovery. CytoRecovery appears to operate as a tools/platform company rather than a therapeutics developer, with revenue generated from instrument and consumables sales rather than a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CytoRecovery.